Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Share Us

Biomanufacturing Strategy Meeting APAC 2018

View: 101

Website | Edit Freely

Category biomanufacturing; biotechnology; drug discovery; Upstream Drug Substance Development

Deadline: May 07, 2018 | Date: May 07, 2018

Venue/Country: Swissotel Merchant Court, Singapore

Updated: 2018-01-11 14:42:17 (GMT+9)

Call For Papers - CFP

Proventa International’s unique format of Biomanufacturing Strategy Meeting 2018 gathers seasoned local and global thought leaders in an exclusive discussion where each C-Level Director gets to share knowledge and insights on key strategic challenges that others are currently facing. This year's Biomanufacturing Strategy Meeting will be held at Swissotel Merchant Court in Singapore on 07 May 2018. For more information, please visit

Who should attend?

This strategic meeting is designed for APAC Senior Executives in charge of Process R&T/R&D/Development & Engineering, Upstream Drug Substance Development and Technology Management, Cell Culture Manufacturing/Cell Line Engineering, Purification Development, Preclinicial Manufacturing, Technology and Standardisation, Quality Operations/Quality Sciences Compliance and Analytical Technology, Validation Manufacturing Science,Risk Management, Bioprocessing R&D Analytics, CMC, Early Stage Bioprocess Development, Product Supply.

Submit your interest to attend, sponsor or partner!

Delegate Registration:

Sponsorship Opportunities:

Media Partnership:

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.